To include your compound in the COVID-19 Resource Center, submit it here.

Ziopharm Oncology, Solasia deal

Ziopharm and Solasia amended a 2011 deal granting Solasia exclusive rights to develop and commercialize IV

Read the full 160 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE